New stent study aims to improve heart outcomes for all, especially diabetics

This study looked at how well the Xience Sierra drug-coated stent works in a broad group of heart disease patients, including those with diabetes or prediabetes. Over 1,700 participants received the stent during a routine procedure to open blocked arteries. Researchers tracked heart-related events like death, heart attack, or need for repeat procedures for up to two years to see if the stent is safe and effective in real-world, high-risk patients.